News Madrigal Pharmaceuticals Appoints Bill Sibold as Chief Executive Officer Continue Reading Previous Madrigal Pharmaceuticals Appoints Bill Sibold as Chief Executive OfficerNext EyePoint Pharmaceuticals Reports Positive Masked Safety Update for Lead Product Candidate EYP-1901 in Ongoing PAVIA and DAVIO 2 Phase 2 Clinical Trials as of September 1, 2023 Related Stories News Lithosphere Deploys Full-Stack Development Environment for AI-Native Applications News Bonnie Keren He Opens Solo Exhibition “INNA BEAUTI” at Flushing Town Hall Gallery News The FUTR Corporation Reports Financial Results for the Six-Month Transition Period Ended December 31, 2025 News Sylogist Announces Release Date for Its First Quarter 2026 Results News BYT Holdings Ltd. Anticipates Failure-to-File Cease Trade Order News Pineapple Financial to Participate in Upcoming May Investor and Industry Conferences
